← brief for 2026-09-23 · Slowing decline

Phase 1a Study Assessing Safety, Tolerability, Pharmacokinetics, and Immunogenicity of PMG1016

Key takeaways

This is a first-in-human trial for a new drug called PMG1016. It will test the drug in healthy adults to check for safety. There are no results yet as the trial is in its early stages.

Who did this work

Run by Pulmongene Ltd..
Sites: Nucleus Network (Brisbane)

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-09-23
https://clinicaltrials.gov/study/NCT07615985